| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3337 | 2020 |
| Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome YM Arabi, Y Mandourah, F Al-Hameed, AA Sindi, GA Almekhlafi, ... American journal of respiratory and critical care medicine 197 (6), 757-767, 2018 | 1306 | 2018 |
| A minimal common outcome measure set for COVID-19 clinical research JC Marshall, S Murthy, J Diaz, NK Adhikari, DC Angus, YM Arabi, K Baillie, ... The lancet infectious diseases 20 (8), e192-e197, 2020 | 1021 | 2020 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1011 | 2020 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 901 | 2022 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 705 | 2020 |
| Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ... MedRxiv, 2020.04. 23.20076042, 2020 | 430 | 2020 |
| ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... Bmj 369, m1985, 2020 | 388 | 2020 |
| Adjunctive dexamethasone in HIV-associated cryptococcal meningitis J Beardsley, M Wolbers, FM Kibengo, ABM Ggayi, A Kamali, NTK Cuc, ... New England Journal of Medicine 374 (6), 542-554, 2016 | 323 | 2016 |
| Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study YM Arabi, S Shalhoub, Y Mandourah, F Al-Hameed, A Al-Omari, ... Clinical infectious diseases 70 (9), 1837-1844, 2020 | 319 | 2020 |
| Intensified antituberculosis therapy in adults with tuberculous meningitis AD Heemskerk, ND Bang, NTH Mai, TTH Chau, NH Phu, PP Loc, ... New England Journal of Medicine 374 (2), 124-134, 2016 | 314 | 2016 |
| Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... The Lancet Regional Health–Europe 8, 2021 | 291 | 2021 |
| Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis NTQ Nhu, D Heemskerk, DDA Thu, TTH Chau, NTH Mai, HDT Nghia, ... Journal of clinical microbiology 52 (1), 226-233, 2014 | 291 | 2014 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 281 | 2021 |
| A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients NM Nguyen, CNB Tran, LK Phung, KTH Duong, HA Huynh, J Farrar, ... The Journal of infectious diseases 207 (9), 1442-1450, 2013 | 259 | 2013 |
| Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Y Arabi, H Balkhy, AH Hajeer, A Bouchama, FG Hayden, A Al-Omari, ... Springerplus 4, 1-8, 2015 | 250 | 2015 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study YM Arabi, A Al-Omari, Y Mandourah, F Al-Hameed, AA Sindi, B Alraddadi, ... Critical care medicine 45 (10), 1683-1695, 2017 | 202 | 2017 |
| Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial J Dunning, F Sahr, A Rojek, F Gannon, G Carson, B Idriss, T Massaquoi, ... PLoS medicine 13 (4), e1001997, 2016 | 191 | 2016 |
| Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19 D Munblit, P Bobkova, E Spiridonova, A Shikhaleva, A Gamirova, ... Clinical & Experimental Allergy 51 (9), 1107-1120, 2021 | 177 | 2021 |
Jake DunningSenior Research Fellow, University of Oxford; Hon. Clin. Ass. Prof, UCLVerified email at ndm.ox.ac.uk
